One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Chemoinformatics Market

[ 英語タイトル ] Chemoinformatics Market - Growth, Trends, and Forecasts (2020 - 2025)

Product Code : MDHC0082882
Survey : Mordor Intelligence
Publish On : November, 2020
Number of Pages : 112
Category : Healthcare and Pharmaceuticals
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4250 / Question Form
5 User USD4750 / Question Form
Enterprise User USD7500 / Question Form
 - Dassault Systemes
- Agilent Technologies
- Bio-rad Laboratories Inc.
- BioSolveIT GmbH
- Cerep Inc.
- ChemAxon Inc.
- Chemical Computing Group Inc.
- Jubilant Biosys Inc.
- Molecular Discovery Ltd
- OpenEye Scientific Software

[Report Description]

The propelling factors for the growth of the global chemoinformatics market include the innovations and advancements in the drug development process and increased demand for personalized medicine. The ever increasing growth of the drug development market is likely to boost the demand for chemoinformatics, owing to its numerous applications in drug designing at various stages. Right from target identification to its development as a potential drug candidate, chemoinformatics tools play a crucial part.

There has also been growing awareness related to personalized medicine, which has been driving the demand for effective medication, coupled with the unsustainable burden of chronic diseases. This serves as a compelling factor for new drug development, which promotes a positive impact on the growth of the global chemoinformatics market. These techniques find a vast array of applications in the various stages of drug designing. Furthermore, with the growing R&D intensity, the segment is further reinforced, owing to technological innovation inputs.

Key Market Trends

Chemical Analysis Segment by Application is Expected to Grow Fastest Over the Forecast Period

The chemical analysis segment accounted for the majority of the revenue share. The major factors that are contributing to the segment’s growth include the increasing investments in R&D and the relatively low success rate of the potential leads as drug molecules.

The factors in conjunction with each other are expected to boost the usage of these platforms. Increasing demand for personalized medicine is a major cause for the market growth. Increasing prevalence of concerned other chronic diseases, which boosts demand for personalized diagnostics and therapeutics, is also one of the key factors responsible for the growth of the segment.

North America Holds the Largest Share and is Expected to Follow the Same Trend Over the Forecast Period

North America is likely to contribute to the largest share in the chemoinformatics market, owing to factors, such as enhanced healthcare of infrastructure, funds in initiatives of R&D, and technological enlargements in the United States and Canada. There has also been an increasing patient awareness about healthcare services and growing demand for personalized medicine that are likely to boost the market growth.

Competitive Landscape

The global chemoinformatics market has gained significant momentum in research institutions, pharmaceutical companies, biotechnology industry, research laboratories, and academic institutions. Therefore it is expected that over the course of time, there may be an influx of well-established players in the chemoinformatics market.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Innovations and Advancements in the Drug Development Process
4.2.2 Increased Demand of Personalized Medicine
4.3 Market Restraints
4.3.1 Cost Associated with Chemoinformatics Software
4.3.2 Lack of Skilled Labors
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Application
5.1.1 Chemical Analysis Chemical Databases Chemo metrics Molecular Modelling Other Chemical Analyses
5.1.2 Drug Discovery and Validation
5.1.3 Virtual Screening
5.1.4 Other Applications
5.2 Geography
5.2.1 North America United States Canada Mexico
5.2.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.2.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.2.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa
5.2.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Dassault Systemes
6.1.2 Agilent Technologies
6.1.3 Bio-rad Laboratories Inc.
6.1.4 BioSolveIT GmbH
6.1.5 Cerep Inc.
6.1.6 ChemAxon Inc.
6.1.7 Chemical Computing Group Inc.
6.1.8 Jubilant Biosys Inc.
6.1.9 Molecular Discovery Ltd
6.1.10 OpenEye Scientific Software




Recommended reports